ABSTRACT
Measures to limit SARS-CoV-2 transmission in 2020 reduced other viral infections. Among 7 US children's hospitals, invasive pneumococcal disease cumulative incidence decreased by 46% in 2020 vs 2017-2019. Limited droplet transmission of pneumococci and preceding viral pathogens may be responsible.
Subject(s)
COVID-19 , Pandemics , Pneumococcal Infections , COVID-19/epidemiology , COVID-19/prevention & control , Child , Humans , Incidence , Pneumococcal Infections/epidemiology , Pneumococcal Infections/prevention & control , United States/epidemiologyABSTRACT
Masking and social distancing have been adopted to mitigate the severe acute respiratory syndrome coronavirus 2 pandemic. We evaluated the indirect impact of severe acute respiratory syndrome coronavirus 2 prevention strategies on invasive Staphylococcus aureus, Streptococcus pneumoniae (pneumococcus) and Group A Streptococcus in Houston area children. We observed a decline in invasive pneumococcal disease and invasive Group A Streptococcus temporally associated with social distancing/masking/school closures.
Subject(s)
COVID-19/epidemiology , Pneumococcal Infections/epidemiology , Staphylococcal Infections/epidemiology , Streptococcal Infections/epidemiology , COVID-19/microbiology , COVID-19/prevention & control , Child , Coinfection/epidemiology , Coinfection/microbiology , Coinfection/virology , Hospitalization , Humans , Pandemics , Pneumococcal Infections/prevention & control , Pneumococcal Infections/virology , Prospective Studies , SARS-CoV-2/isolation & purification , Staphylococcal Infections/prevention & control , Staphylococcal Infections/virology , Staphylococcus aureus/isolation & purification , Streptococcal Infections/prevention & control , Streptococcal Infections/virology , Streptococcus pneumoniae/isolation & purification , Streptococcus pyogenes/isolation & purificationABSTRACT
We describe the clinical course of 57 children with coronavirus disease 2019 (COVID-19) cared for through a single hospital system. Most children were mildly symptomatic, and only a few patients with underlying medical conditions required hospitalization. Systemwide patient evaluation processes allowed for prompt identification and management of patients with COVID-19.